(Q46972456)

27 December 2017

title

Cysteine misincorporation in bacterially expressed human alpha-synuclein (English)

1 reference

27 December 2017

1 reference

3

1 reference

27 December 2017

author name string

Masami Masuda

1

1 reference

27 December 2017

Naoshi Dohmae

2

1 reference

27 December 2017

Takayuki Oikawa

4

1 reference

27 December 2017

Shin-ichi Hisanaga

5

1 reference

27 December 2017

Michel Goedert

6

1 reference

27 December 2017

Masato Hasegawa

7

1 reference

27 December 2017

language of work or name

English

0 references

publication date

24 February 2006

1 reference

27 December 2017

published in

FEBS Letters

1 reference

27 December 2017

volume

580

1 reference

27 December 2017

issue

7

1 reference

27 December 2017

page(s)

1775-1779

1 reference

27 December 2017

Alpha-synuclein and neurodegenerative diseases

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.02.032

Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.02.032

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.02.032

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.02.032

The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.02.032

Gene dosage and pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.02.032

Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.02.032

Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.02.032

Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.02.032

Oxidative dimer formation is the critical rate-limiting step for Parkinson's disease alpha-synuclein fibrillogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.02.032

Identification of two distinct synucleins from human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.02.032

A novel MALDI LIFT-TOF/TOF mass spectrometer for proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.02.032

Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.02.032

Tyrosine-to-cysteine modification of human alpha-synuclein enhances protein aggregation and cellular toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.02.032

10.1016/J.FEBSLET.2006.02.032

21 January 2018

Identifiers

DOI

1 reference

27 December 2017

1 reference

27 December 2017